These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33789635)

  • 1. The EPICURE study: a pilot prospective cohort study of heterogeneous and massive data integration in metastatic breast cancer patients.
    Colombié M; Jézéquel P; Rubeaux M; Frenel JS; Bigot F; Seegers V; Campone M
    BMC Cancer; 2021 Mar; 21(1):333. PubMed ID: 33789635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective construction and validation of a prognostic score to identify patients who benefit from third-line chemotherapy for metastatic breast cancer in terms of overall survival: the METAL3 Study.
    Filleron T; Bonnetain F; Mancini J; Martinez A; Roché H; Dalenc F
    Contemp Clin Trials; 2015 Jan; 40():1-8. PubMed ID: 25460338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and efficacy of a supervised home-based physical exercise program for metastatic cancer patients receiving oral targeted therapy: study protocol for the phase II/III - UNICANCER SdS 01 QUALIOR trial.
    Joly F; Lefeuvre-Plesse C; Garnier-Tixidre C; Helissey C; Menneveau N; Zannetti A; Salas S; Houede N; Abadie-Lacourtoisie S; Stefani L; Nenan S; Rieger I; Durand-Zaleski I; Descotes JM; Anota A
    BMC Cancer; 2020 Oct; 20(1):975. PubMed ID: 33036567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.
    Wallwiener M; Matthies L; Simoes E; Keilmann L; Hartkopf AD; Sokolov AN; Walter CB; Sickenberger N; Wallwiener S; Feisst M; Gass P; Fasching PA; Lux MP; Wallwiener D; Taran FA; Rom J; Schneeweiss A; Graf J; Brucker SY
    J Med Internet Res; 2017 Sep; 19(9):e322. PubMed ID: 28912116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician's choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer.
    Miller K; Cortes J; Hurvitz SA; Krop IE; Tripathy D; Verma S; Riahi K; Reynolds JG; Wickham TJ; Molnar I; Yardley DA
    BMC Cancer; 2016 Jun; 16():352. PubMed ID: 27259714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
    Rinnerthaler G; Gampenrieder SP; Petzer A; Burgstaller S; Fuchs D; Rossmann D; Balic M; Egle D; Rumpold H; Singer CF; Bartsch R; Petru E; Melchardt T; Ulmer H; Mlineritsch B; Greil R
    BMC Cancer; 2018 Nov; 18(1):1074. PubMed ID: 30400780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health services research in patients with breast cancer (CAMISS-prospective): study protocol for an observational prospective study.
    García-Gutierrez S; Orive M; Sarasqueta C; Legarreta MJ; Gonzalez N; Redondo M; Rivero A; Serrano-Aguilar P; Castells X; Quintana JM; Sala M;
    BMC Cancer; 2018 Jan; 18(1):54. PubMed ID: 29310641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From prospective clinical trial to reducing social inequalities in health: The DESSEIN trial, concept and design of a multidisciplinary study in precarious patients with breast cancer.
    Ngô C; Dinut A; Bochaton A; Charreire H; Desprès C; Baffert S; Lécuru F; Chatellier G
    BMC Public Health; 2019 Nov; 19(1):1450. PubMed ID: 31684919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers.
    Mariette C; Renaud F; Piessen G; Gele P; Copin MC; Leteurtre E; Delaeter C; Dib M; Clisant S; Harter V; Bonnetain F; Duhamel A; Christophe V; Adenis A;
    BMC Cancer; 2018 Feb; 18(1):139. PubMed ID: 29409462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
    Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
    Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring Diet, Physical Activity, and Quality of Life in Females with Metastatic Breast Cancer: A Pilot Study to Support Future Intervention.
    Sheean P; Kabir C; Rao R; Hoskins K; Stolley M
    J Acad Nutr Diet; 2015 Oct; 115(10):1690-8. PubMed ID: 25975457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME).
    Pérol D; Robain M; Arveux P; Mathoulin-Pélissier S; Chamorey E; Asselain B; Berchery D; Gourgou S; Breton M; Delaine-Clisant S; Mons M; Diéras V; Carton M; Guizard AV; Laborde L; Laurent C; Loeb A; Mouret-Reynier MA; Parent D; Perrocheau G; Campion L; Velten M; Cailliot C; Ezzalfani M; Simon G
    BMJ Open; 2019 Feb; 9(2):e023568. PubMed ID: 30796119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of years of life after diagnosis of breast cancer using omics and omic-by-treatment interactions.
    González-Reymúndez A; de Los Campos G; Gutiérrez L; Lunt SY; Vazquez AI
    Eur J Hum Genet; 2017 May; 25(5):538-544. PubMed ID: 28272536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PREgnancy and FERtility (PREFER) study: an Italian multicenter prospective cohort study on fertility preservation and pregnancy issues in young breast cancer patients.
    Lambertini M; Anserini P; Fontana V; Poggio F; Iacono G; Abate A; Levaggi A; Miglietta L; Bighin C; Giraudi S; D'Alonzo A; Blondeaux E; Buffi D; Campone F; Merlo DF; Del Mastro L
    BMC Cancer; 2017 May; 17(1):346. PubMed ID: 28526012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
    Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective clinical and biological database for pancreatic adenocarcinoma: the BACAP cohort.
    Canivet C; Gourgou-Bourgade S; Napoléon B; Palazzo L; Flori N; Guibert P; Piessen G; Farges-Bancel D; Seitz JF; Assenat E; Vendrely V; Truant S; Vanbiervliet G; Berthelémy P; Garcia S; Gomez-Brouchet A; Buscail L; Bournet B;
    BMC Cancer; 2018 Oct; 18(1):986. PubMed ID: 30326968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter study investigating the molecular fingerprint of psychological resilience in breast cancer patients: study protocol of the SCAN-B resilience study.
    Axelsson U; Rydén L; Johnsson P; Edén P; Månsson J; Hallberg IR; Borrebaeck CAK
    BMC Cancer; 2018 Aug; 18(1):789. PubMed ID: 30081937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical Activity for Symptom Management in Women With Metastatic Breast Cancer: A Randomized Feasibility Trial on Physical Activity and Breast Metastases.
    Yee J; Davis GM; Hackett D; Beith JM; Wilcken N; Currow D; Emery J; Phillips J; Martin A; Hui R; Harrison M; Segelov E; Kilbreath SL
    J Pain Symptom Manage; 2019 Dec; 58(6):929-939. PubMed ID: 31374368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.